BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5601842)

  • 1. [Various peculiarities in the excretion of catecholamines in depressive states].
    Kodinets-Morozova LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(12):1815-20. PubMed ID: 5601842
    [No Abstract]   [Full Text] [Related]  

  • 2. [Catecholamines in manic-depressive psychoses].
    Baru AM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1358-61. PubMed ID: 5700609
    [No Abstract]   [Full Text] [Related]  

  • 3. Electroconvulsive therapy: effect on catecholamine excretion by psychiatric patients.
    Messiha FS; Turek I
    Res Commun Chem Pathol Pharmacol; 1970 Jul; 1(4):535-46. PubMed ID: 5524262
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the urinary excretion of vanillylmandelic acid during depressive syndromes, maniacal states and mixed states].
    Catalano A; Campanini T; De Risio C; Ridolo P
    Sist Nerv; 1966; 18(2):100-23. PubMed ID: 5929064
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dynamics of the psychopathologic structure and excretion of catecholamines in the process of treating patients with paranoic and paranoid syndromes].
    Vovin RIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(12):1825-31. PubMed ID: 5628793
    [No Abstract]   [Full Text] [Related]  

  • 6. [Excretion of 3-methoxy-4-hydroxy-amygdalic acid and 5-hydroxyindoleacetic acid in the urine of patients with depressive states].
    Slowik S
    Przegl Lek; 1968; 24(3):367-70. PubMed ID: 5676274
    [No Abstract]   [Full Text] [Related]  

  • 7. Catecholamine measures for diagnosis and treatment of patients with depressive disorders.
    Schatzberg AF; Orsulak PJ; Rosenbaum AH; Kruger ER; Schildkraut JJ; Cole JO
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):35-9. PubMed ID: 7440524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical changes in psychotic depression. High norepinephrine levels in psychotic vs neurotic depression.
    Bunney WE; Davis JM; Weil-Malherbe H; Smith ER
    Arch Gen Psychiatry; 1967 Apr; 16(4):448-60. PubMed ID: 6022709
    [No Abstract]   [Full Text] [Related]  

  • 9. [Catecholamine changes in patients with depression under the action of high-intensity light].
    Tsarytsyns'kyĭ VI; Striliana OI; Bozhko HKh; Tarans'ka AD
    Lik Sprava; 1996; (3-4):84-6. PubMed ID: 9035891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution of urinary catecholamine determination to psychology, psychosomatic medicine and psychiatry].
    Frankignoul M
    Rev Med Psychosom Psychol Med; 1969; 11(3):371-84. PubMed ID: 5409036
    [No Abstract]   [Full Text] [Related]  

  • 11. [Excretion of vanilmandelic acid in depressive syndromes of various etiology].
    Schrammowa H; Nowak S; Lisowska J; Czerwiński A
    Psychiatr Pol; 1971; 5(1):1-6. PubMed ID: 5551986
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of aminazine on the excretion of adrenaline noradrenaline, dopamine and dopa in healthy subjects and in the manic phase of manic-depressive psychosis].
    Matlina ESh; Osipova MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(1):128-31. PubMed ID: 5448719
    [No Abstract]   [Full Text] [Related]  

  • 13. Excretion of catecholamines and tryptophan derivatives in schizophrenia.
    Mileikovskii YA
    Neurosci Behav Physiol; 1979; 9(4):325-8. PubMed ID: 158714
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
    Vasil'ev VN
    Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The urinary excretion of adrenaline and noradrenaline by depressive patients during iproniazid treatment.
    CARLSSON A; RASMUSSEN EB; KRISTJANSEN P
    J Neurochem; 1959 Oct; 4():321-4. PubMed ID: 13807779
    [No Abstract]   [Full Text] [Related]  

  • 16. Excretion of catecholamines and metabolites in response to increased dietary phosphate intake.
    Berndt TJ; MacDonald A; Walikonis R; Chinnow S; Dousa TP; Tyce GM; Knox FG
    J Lab Clin Med; 1993 Jul; 122(1):80-4. PubMed ID: 8320494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Work-stress and urinary catecholamines excretion in shift workers exposed to noise. I: Epinephrine (E) and nor-epinephrine (NE).
    Cesana GC; Ferrario M; Curti R; Zanettini R; Grieco A; Sega R; Palermo A; Mara G; Libretti A; Algeri S
    Med Lav; 1982; 73(2):99-109. PubMed ID: 7202110
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary excretion of catecholamines by full-term and premature infants.
    Nicolopoulos D; Agathopoulos A; Galanakos-Tharouniati M; Stergiopoulos C
    Pediatrics; 1969 Aug; 44(2):262-5. PubMed ID: 5806257
    [No Abstract]   [Full Text] [Related]  

  • 19. [Excretion of catecholamines in the urine of patients with neurodermatitis].
    Chistiakov AF
    Vestn Dermatol Venerol; 1969 Dec; 45(12):40-5. PubMed ID: 5375467
    [No Abstract]   [Full Text] [Related]  

  • 20. Schizophrenia and pink spot.
    Stam FC; Heslinga FJ; van Tilburg W
    Psychiatr Neurol Neurochir; 1969; 72(6):513-24. PubMed ID: 5369242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.